Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value

$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — Foreign Currency Impact ($M) ($M)

Medtronic Form 8-K World-Wide Revenue Tables (Currency Impact)

Quarterly Annual

Latest, Q4 FY23

-20

Period ended Apr 30, 2023

Change on a year earlier

-13.0%

-23 in Q4 FY22

History

22 quarters

Since Q3 FY18

Sources

Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — Foreign Currency Impact ($M) ($M)	Year on year	Source
Q4 FY23	Apr 30, 2023	-20	-13.0%	Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗
Q3 FY23	Jan 31, 2023	-36	+125.0%	Medtronic SEC 8K_EARNINGS — FY2023Q3 (filed 2023-02-21) ↗
Q2 FY23	Oct 31, 2022	-42	-1,500.0%	Medtronic SEC 8K_EARNINGS — FY2023Q2 (filed 2022-11-22) ↗
Q1 FY23	Jul 31, 2022	-34	-247.8%	Medtronic SEC 8K_EARNINGS — FY2023Q1 (filed 2022-08-23) ↗
Q4 FY22	Apr 30, 2022	-23	-200.0%	Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗
Q3 FY22	Jan 31, 2022	-16	-260.0%	Medtronic SEC 8K_EARNINGS — FY2022Q3 (filed 2022-02-22) ↗
Q2 FY22	Oct 31, 2021	3	+200.0%	Medtronic SEC 8K_EARNINGS — FY2022Q2 (filed 2021-11-23) ↗
Q1 FY22	Jul 31, 2021	23	-291.7%	Medtronic SEC 8K_EARNINGS — FY2022Q1 (filed 2021-08-24) ↗
Q4 FY21	Apr 30, 2021	23	-243.7%	Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗
Q3 FY21	Jan 31, 2021	10	-433.3%	Medtronic SEC 8K_EARNINGS — FY2021Q3 (filed 2021-02-23) ↗
Q2 FY21	Oct 31, 2020	1	-116.7%	Medtronic SEC 8K_EARNINGS — FY2021Q2 (filed 2020-11-24) ↗
Q1 FY21	Jul 31, 2020	-12	-200.0%	Medtronic SEC 8K_EARNINGS — FY2021Q1 (filed 2020-08-25) ↗
Q4 FY20	Apr 30, 2020	-16	-166.7%	Medtronic SEC 8K_EARNINGS — FY2020Q4 (filed 2020-05-21) ↗
Q3 FY20	Jan 31, 2020	-3	-123.1%	Medtronic SEC 8K_EARNINGS — FY2020Q3 (filed 2020-02-18) ↗
Q2 FY20	Oct 31, 2019	-6	-166.7%	Medtronic SEC 8K_EARNINGS — FY2020Q2 (filed 2019-11-19) ↗
Q1 FY20	Jul 31, 2019	12	+71.4%	Medtronic SEC 8K_EARNINGS — FY2020Q1 (filed 2019-08-20) ↗
Q4 FY19	Apr 30, 2019	24	-11.1%	Medtronic SEC 8K_EARNINGS — FY2019Q4 (filed 2019-05-23) ↗
Q3 FY19	Jan 31, 2019	13	-7.1%	Medtronic SEC 8K_EARNINGS — FY2019Q3 (filed 2019-02-19) ↗
Q2 FY19	Oct 31, 2018	9	–	Medtronic SEC 8K_EARNINGS — FY2019Q2 (filed 2018-11-20) ↗
Q1 FY19	Jul 31, 2018	7	–	Medtronic SEC 8K_EARNINGS — FY2019Q1 (filed 2018-08-21) ↗
Q4 FY18	Apr 30, 2018	27	–	Medtronic SEC 8K_EARNINGS — FY2018Q4 (filed 2018-05-24) ↗
Q3 FY18	Jan 31, 2018	14	–	Medtronic SEC 8K_EARNINGS — FY2018Q3 (filed 2018-02-20) ↗

Cite this data

StockData. (2026). Medtronic Respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — Foreign Currency Impact ($M) ($M), quarterly Q3 FY18–Q4 FY23 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ms-rgr-leg-ww-fx

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.